Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-30T19:11:17.498Z Has data issue: false hasContentIssue false
  • English
  • Français

Relapse of drunk driving and association with traffic accidents, alcohol-related problems and biomarkers of impulsivity

Published online by Cambridge University Press:  26 November 2018

Tõnis Tokko ,
Diva Eensoo ,
Mariliis Vaht ,
Klaus-Peter Lesch ,
Andreas Reif  and
Jaanus Harro Open the ORCID record for Jaanus Harro [Opens in a new window]
Tõnis Tokko
Affiliation:
Division of Neuropsychopharmacology, Department of Psychology, University of Tartu, Estonia
Diva Eensoo
Affiliation:
Department of Family Medicine and Public Health, University of Tartu, Estonia
Mariliis Vaht
Affiliation:
Division of Neuropsychopharmacology, Department of Psychology, University of Tartu, Estonia
Klaus-Peter Lesch
Affiliation:
Division of Molecular Psychiatry, Center of Mental Health, University of Wuerzburg, Wuerzburg, Germany, b) Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Moscow, Russia, c) Department of Neuroscience, School for Mental Health and Neuroscience (MHeNS), Maastricht University, Maastricht, The Netherlands
Andreas Reif
Affiliation:
Laboratory of Translational Psychiatry, Department of Psychiatry, Psychosomatic Medicine, and Psychotherapy, University Hospital Frankfurt, Frankfurt am Main, Germany
Jaanus Harro*
Affiliation:
Division of Neuropsychopharmacology, Department of Psychology, University of Tartu, Estonia
*
Author for correspondence: Jaanus Harro, Division of Neuropsychopharmacology, Department of Psychology, University of Tartu, Estonian Centre of Behavioural and Health Sciences, Ravila 14A Chemicum, 50411 Tartu, Estonia. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective

Individual biological predispositions should play a role in risky driving behaviour. Platelet monoamine oxidase (MAO) activity, dopamine transporter gene (DAT1) and neuropeptide S receptor 1 (NPSR1) gene polymorphisms have been identified as markers of impulsivity, alcohol use and excessive risk-taking. We aimed to find out how this knowledge on neurobiology of impulsivity applies to drunk driving and traffic behaviour in general.

Methods

We have longitudinally examined the behaviour of drunk drivers (n = 203) and controls (n = 211) in traffic, in association with their alcohol-related problems, personality measures and the three biomarkers. We analysed differences between the subjects based on whether they had committed driving while impaired by alcohol (DWI) violation in a 10-year time period after recruitment or not and investigated further, what kind of predictive value do the different biomarkers have in committing DWI and other traffic violations and accidents.

Results

The original drunk drivers group had lower platelet MAO activity but further DWI was not significantly associated with this measure. Being a NPSR1 T-allele carrier contributed to the risk of repeatedly committing DWI. DAT1 9R carriers in contrast were involved in more traffic accidents by their own fault (active accidents), compared to 10R homozygotes in the whole sample. All groups with DWI also had significantly more alcohol-related problems and higher scores in maladaptive impulsivity compared to controls without DWI.

Conclusions

Established biological markers of alcohol use and impulsivity can be reliably associated with everyday traffic behaviour and help in contributing to the understanding of the need for more personalized prevention activities.

Keywords

biomarkersdriving under the influenceimpulsive behaviour
Type
Original Article
Information
Acta Neuropsychiatrica , Volume 31 , Issue 2 , April 2019 , pp. 84 - 92
Copyright
© Scandinavian College of Neuropsychopharmacology 2018 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. World Health Organization (2015) Global status report on road safety 2015. Geneva: World Health Organization.Google Scholar
2. Evans, L (1993) Comments on driver behavior and its role in traffic crashes. Alcohol Drugs Driving 9, 185–195.Google Scholar
3. Hels, T, Lyckegaard, A, Simonsen, KW, Steentoft, A and Bernhoft, IM (2013) Risk of severe driver injury by driving with psychoactive substances. Accid Anal Prev 59, 346–356.Google Scholar
4. Stacy, AW, Newcomb, MD and Bentler, PM (1991) Personality, problem drinking, and drunk driving: Mediating, moderating, and direct-effect models. J Pers Soc Psychol 60, 795–811.Google Scholar
5. Lapham, SC, Smith, E, C’de Baca, J, Chang, I, Skipper, BJ, Baum, G and Hunt, WC (2001) Prevalence of psychiatric disorders among persons convicted of driving while impaired. Arch Gen Psychiatry 58, 943–949.Google Scholar
6. Dickman, SJ (1990) Functional and dysfunctional impulsivity: Personality and cognitive correlates. J Pers Soc Psychol 58, 95–102.Google Scholar
7. Eensoo, D, Paaver, M, Pulver, A, Harro, M and Harro, J (2004) Low platelet MAO activity associated with high dysfunctional impulsivity and antisocial behavior: evidence from drunk drivers. Psychopharmacol 172, 356–358.Google Scholar
8. Paaver, M, Eensoo, D, Pulver, A and Harro, J (2006) Adaptive and maladaptive impulsivity, platelet monoamine oxidase (MAO) activity and risk-admitting in different types of risky drivers. Psychopharmacol 186, 32–40.Google Scholar
9. Eensoo, D, Paaver, M, Harro, M and Harro, J (2005) Predicting drunk driving: contribution of alcohol use and related problems, traffic behaviour, personality and platelet monoamine oxidase (MAO) activity. Alcohol Alcohol 40, 140–146.Google Scholar
10. von Knorring, L, Oreland, L and Winblad, B (1984) Personality traits related to monoamine oxidase activity in platelets. Psychiatry Res 12, 11–26.Google Scholar
11. Oreland, L (1993) Monoamine oxidase in neuro-psychiatric disorders. In: Yasuhar H, Parves SH, Oguchi K, Sandler M and Nagatsu T, editors. Monoamine Oxidase: Basic and Clinical Aspects. Utrecht: VSP; p. 219–247.Google Scholar
12. Oreland, L (2004) Platelet monoamine oxidase, personality and alcoholism: the rise, fall and resurrection. Neurotoxicol 25, 79–89.Google Scholar
13. von Knorring, L and Oreland, L (1996) Platelet MAO activity in type 1/type 2 alcoholics. Alcohol Clin Exp Res 20, 224a–230a.Google Scholar
14. Sabre, L, Harro, J, Eensoo, D, Vaht, M, Kabel, V, Pakkanen, M, Asser, T and Kõrv, J (2016) A new risk factor for traumatic spinal cord injury. J Neurotrauma 33, 1946–1949.Google Scholar
15. Stalenheim, EG (2004) Long-term validity of biological markers of psychopathy and criminal recidivism: follow-up 6–8 years after forensic psychiatric investigation. Psychiatry Res 121, 281–291.Google Scholar
16. Oreland, L, Nilsson, K, Damberg, M and Hallman, J (2007) Monoamine oxidases—activities, genotypes and the shaping of behaviour. J Neural Transm 114, 817–822.Google Scholar
17. Jokinen, J, Königsson, J, Moberg, T, Jönsson, EG, Tiihonen, J, Nordström, P, Oreland, L and Åsberg, M (2018) Platelet monoamine oxidase activity and interpersonal violence in male suicide attempters. Psychiatry Res 260, 173–176.Google Scholar
18. Harro, J and Oreland, L (2016) The role of MAO in personality and drug use. Prog Neuropsychopharmacol Biol Psychiatry 69, 101–111.Google Scholar
19. Ikemoto, S and Panksepp, J (1999) The role of nucleus accumbens dopamine in motivated behavior: a unifying interpretation with special reference to reward-seeking. Brain Res Rev 31, 6–41.Google Scholar
20. Bergh, C, Eklund, T, Södersten, P and Nordin, C (1997) Altered dopamine function in pathological gambling. Psychol Med 27, 473–475.Google Scholar
21. Thapar, A, O’donovan, M and Owen, MJ (2005) The genetics of attention deficit hyperactivity disorder. Hum Mol Genet 14, R275–R282.Google Scholar
22. Barkley, RA, Murphy, KR, Dupaul, GJ and Bush, T (2002) Driving in young adults with attention deficit hyperactivity disorder: knowledge, performance, adverse outcomes, and the role of executive functioning. J Int Neuropsychol Soc 8, 655–672.Google Scholar
23. Fried, R, Petty, C, Surman, C, Reimer, B, Aleardi, M, Martin, J, Coughlin, J and Biederman, J (2006) Characterizing impaired driving in adults with ADHD: a controlled study. J Clin Psychiatry 67, 567–574.Google Scholar
24. Puumala, T and Sirviö, J (1998) Changes in activities of dopamine and serotonin systems in the frontal cortex underlie poor choice accuracy and impulsivity of rats in an attention task. Neuroscience 83, 489–499.Google Scholar
25. Winstanley, CA, Theobald, DE, Dalley, JW, Cardinal, RN and Robbins, TW (2005) Double dissociation between serotonergic and dopaminergic modulation of medial prefrontal and orbitofrontal cortex during a test of impulsive choice. Cereb Cortex 16, 106–114.Google Scholar
26. De Wit, H, Enggasser, JL and Richards, JB (2002) Acute administration of d-amphetamine decreases impulsivity in healthy volunteers. Neuropsychopharmacol 27, 813–825.Google Scholar
27. Friedel, RO (2004) Dopamine dysfunction in borderline personality disorder: a hypothesis. Neuropsychopharmacol 29, 1029–1039.Google Scholar
28. Chen, N and Reith, ME (2000) Structure and function of the dopamine transporter. Eur J Pharmacol 405, 329–339.Google Scholar
29. Costa, A, Riedel, M, Müller, U, Möller, HJ and Ettinger, U (2011) Relationship between SLC6A3 genotype and striatal dopamine transporter availability: a meta-analysis of human single photon emission computed tomography studies. Synapse 65, 998–1005.Google Scholar
30. van de Giessen, EM, de Win, MM, Tanck, MW, van den Brink, W, Baas, F and Booij, J (2009) Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3. J Nucl Med 50, 45–52.Google Scholar
31. Faraone, SV, Spencer, TJ, Madras, BK, Zhang-James, Y and Biederman, J (2014) Functional effects of dopamine transporter gene genotypes on in vivo dopamine transporter functioning: a meta-analysis. Mol Psychiatry, 19, 880–889.Google Scholar
32. Ma, Y, Fan, R and Li, MD (2016) Meta‐Analysis Reveals Significant Association of the 3′‐UTR VNTR in SLC 6A3 with Alcohol Dependence. Alcohol Clin Exp Res 40, 1443–1453.Google Scholar
33. Franke, B, Vasquez, AA, Johansson, S, Hoogman, M, Romanos, J, Boreatti-Hümmer, A, Heine, M, Jacob, CP, Lesch, KP, Casas, M and Ribasés, M (2010) Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD. Neuropsychopharmacol 35, 656–664.Google Scholar
34. Forbes, EE, Brown, SM, Kimak, M, Ferrell, RE, Manuck, SB and Hariri, AR (2009) Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. Mol Psychiatry 14, 60–70.Google Scholar
35. Pearson, MR, Murphy, EM and Doane, AN (2013) Impulsivity-like traits and risky driving behaviors among college students. Accid Anal Prev 53, 142–148.Google Scholar
36. Ghazal, P (2016) The physio-pharmacological role of the NPS/NPSR system in psychiatric disorders: a translational overview. Curr Protein Pept Sci 17, 380–397.Google Scholar
37. Si, W, Aluisio, L, Okamura, N, Clark, SD, Fraser, I, Sutton, SW, Bonaventure, P and Reinscheid, RK (2010) Neuropeptide S stimulates dopaminergic neurotransmission in the medial prefrontal cortex. J Neurochem 115, 475–482.Google Scholar
38. Dannlowski, U, Kugel, H, Franke, F, Stuhrmann, A, Hohoff, C, Zwanzger, P, Lenzen, T, Grotegerd, D, Suslow, T, Arolt, V and Heindel, W (2011) Neuropeptide-S (NPS) receptor genotype modulates basolateral amygdala responsiveness to aversive stimuli. Neuropsychopharmacol 36, 1879–1885.Google Scholar
39. Laas, K, Reif, A, Kiive, E, Domschke, K, Lesch, KP, Veidebaum, T and Harro, J (2014) A functional NPSR1 gene variant and environment shape personality and impulsive action: a longitudinal study. J Psychopharmacol 28, 227–236.Google Scholar
40. Laas, K, Reif, A, Akkermann, K, Kiive, E, Domschke, K, Lesch, KP, Veidebaum, T and Harro, J (2014) Interaction of the neuropeptide S receptor gene Asn107Ile variant and environment: contribution to affective and anxiety disorders, and suicidal behaviour. Int J Neuropsychopharmacol 17, 541–552.Google Scholar
41. Laas, K, Reif, A, Akkermann, K, Kiive, E, Domschke, K, Lesch, KP, Veidebaum, T and Harro, J (2015) Neuropeptide S receptor gene variant and environment: contribution to alcohol use disorders and alcohol consumption. Addict Biol 20, 605–616.Google Scholar
42. Laas, K, Eensoo, D, Paaver, M, Lesch, KP, Reif, A and Harro, J (2015) Further evidence for the association of the NPSR1 gene A/T polymorphism (Asn107Ile) with impulsivity and hyperactivity. J Psychopharmacol 29, 878–883.Google Scholar
43. Reinscheid, RK, Xu, YL, Okamura, N, Zeng, J, Chung, S, Pai, R, Wang, Z and Civelli, O (2005) Pharmacological characterization of human and murine neuropeptide s receptor variants. J Pharmacol Exp Ther 315, 1338–1345.Google Scholar
44. Taranov, AO, Puchkova, AN, Slominsky, PA, Tupitsyna, TV, Dementiyenko, VV and Dorokhov, VB (2017) Associations between chronotype, road accidents and polymorphisms in genes linked with biological clock and dopaminergic system. ZH NEVROL PSIKHIATR 117, 28–33.Google Scholar
45. Laas, K, Reif, A, Herterich, S, Eensoo, D, Lesch, KP and Harro, J (2010) The effect of a functional NOS1 promoter polymorphism on impulsivity is moderated by platelet MAO activity. Psychopharmacol 209, 255–261.Google Scholar
46. Hallman, J, Oreland, L, Edman, G and Schalling, D (1987) Thrombocyte monoamine oxidase activity and personality traits in women with severe premenstrual syndrome. Acta Psychiatr Scand 76, 225–234.Google Scholar
47. Harro, M, Eensoo, D, Kiive, E, Merenäkk, L, Alep, J, Oreland, L and Harro, J (2001) Platelet monoamine oxidase in healthy 9-and 15-years old children: the effect of gender, smoking and puberty. Prog Neuropsychopharmacol Biol Psychiatry 25, 1497–1511.Google Scholar
48. Maksimov, M, Vaht, M, Murd, C, Harro, J and Bachmann, T (2015) Brain dopaminergic system related genetic variability interacts with target/mask timing in metacontrast masking. Neuropsychol 71, 112–118.Google Scholar
49. Bannon, MJ, Michelhaugh, SK, Wang, J and Sacchetti, P (2001) The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvement in neuropsychiatric disorders. Eur Neuropsychopharmacol 11, 449–455.Google Scholar
50. Domschke, K, Reif, A, Weber, H, Richter, J, Hohoff, C, Ohrmann, P, Pedersen, A, Bauer, J, Suslow, T, Kugel, H and Heindel, W (2011) Neuropeptide S receptor gene—converging evidence for a role in panic disorder. Mol Psychiatry 16, 938–948.Google Scholar
51. Fowler, JS, Logan, J, Wang, GJ and Volkow, ND (2003) Monoamine oxidase and cigarette smoking. Neurotoxicol 24, 75–82.Google Scholar
52. Warren-Kigenyi, N and Coleman, H. DWI Recidivism in the United States: An Examination of State-Level Driver Data and the Effect of Look-Back Periods on Recidivism Prevalence. Traffic Safety Facts Research Note 2014; DOT HS 811 991. NHTSA.Google Scholar
53. Harro, J, Fischer, K, Vansteelandt, S and Harro, M (2004) Both low and high activities of platelet monoamine oxidase increase the probability of becoming a smoker. Eur Neuropsychopharmacol 14, 65–69.Google Scholar
54. Dorokhov, VB, Puchkova, AN, Taranov, AO, Ermolayev, VV, Tupitsyna, TV, Slominsky, PA and Dementiyenko, VV (2017) Polymorphisms in sleep and cognitive function related genes are associated with vehicle crash history in shift working bus drivers. ZH VYSSH NERV DEYAT+ 67, 49–54.Google Scholar
55. Paaver, M, Eensoo, D, Kaasik, K, Vaht, M, Mäestu, J and Harro, J (2013) Preventing risky driving: A novel and efficient brief intervention focusing on acknowledgement of personal risk factors. Accid Anal Prev 50, 430–437.Google Scholar
56. Eensoo, D, Paaver, M, Vaht, M, Loit, HM and Harro, J (2018) Risky driving and the persistent effect of a randomized intervention focusing on impulsivity: the role of the serotonin transporter promoter polymorphism. Accid Anal Prev 113, 19–24.Google Scholar
57. Sloan, FA, Eldred, LM and Davis, DV (2014) Addiction, drinking behavior, and driving under the influence. Subst Use Misuse 49, 661–676.Google Scholar